BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 7688026)

  • 1. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide.
    Khoury SJ; Sayegh MH; Hancock WW; Gallon L; Carpenter CB; Weiner HL
    J Exp Med; 1993 Aug; 178(2):559-66. PubMed ID: 7688026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo.
    Khoury SJ; Gallon L; Chen W; Betres K; Russell ME; Hancock WW; Carpenter CB; Sayegh MH; Weiner HL
    J Exp Med; 1995 Aug; 182(2):357-66. PubMed ID: 7543136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired thymic tolerance and experimental allergic encephalomyelitis in the rat. I. Parameters and analysis of possible mechanisms.
    Wilson DB; Wilson DH; Schroder K
    Eur J Immunol; 1998 Sep; 28(9):2770-9. PubMed ID: 9754564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically.
    Goss JA; Nakafusa Y; Roland CR; Hickey WF; Flye MW
    J Immunol; 1994 Nov; 153(9):3890-8. PubMed ID: 7523508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice.
    Kono DH; Urban JL; Horvath SJ; Ando DG; Saavedra RA; Hood L
    J Exp Med; 1988 Jul; 168(1):213-27. PubMed ID: 2456367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis.
    Javed NH; Gienapp IE; Cox KL; Whitacre CC
    J Immunol; 1995 Aug; 155(3):1599-605. PubMed ID: 7543526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.
    Li HL; Liu JQ; Bai XF; vn der Meide PH; Link H
    Immunology; 1998 Jul; 94(3):431-7. PubMed ID: 9767428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of timing of intravenous administration of myelin basic protein on the induction of tolerance in experimental allergic encephalomyelitis.
    Hilliard B; Ventura ES; Rostami A
    Mult Scler; 1999 Feb; 5(1):2-9. PubMed ID: 10096096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats.
    Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y
    J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells.
    Duplan V; Dutartre P; Mars LT; Liblau RS; Druet P; Saoudi A
    J Immunol; 2003 Feb; 170(4):2179-85. PubMed ID: 12574391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
    Saoudi A; Simmonds S; Huitinga I; Mason D
    J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats.
    Pope L; Paterson PY; Miller SD
    J Neuroimmunol; 1992 Apr; 37(3):177-89. PubMed ID: 1373153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope and functional specificity of peripheral tolerance induction in experimental autoimmune encephalomyelitis in adult Lewis rats.
    Malotky MK; Pope L; Miller SD
    J Immunol; 1994 Jul; 153(2):841-51. PubMed ID: 7517425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic and non-pathogenic T lymphocytes specific for the encephalitogenic epitope of myelin basic protein: functional characteristics and vaccination properties.
    Beraud E; Balzano C; Zamora AJ; Varriale S; Bernard D; Ben-Nun A
    J Neuroimmunol; 1993 Aug; 47(1):41-53. PubMed ID: 7690770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
    Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
    Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired thymic tolerance to autoimmune encephalomyelitis is associated with activation of peripheral IL-10-producing macrophages/dendritic cells.
    Okura Y; Jee Y; Matsumoto Y
    Int Immunol; 2003 Mar; 15(3):437-46. PubMed ID: 12618488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
    Hilliard BA; Kamoun M; Ventura E; Rostami A
    Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization.
    Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking of V beta 8.2-positive encephalitogenic T cells by complementarity-determining region 3 spectratyping and subsequent Southern blot hybridization in Lewis rats after neuroantigen sensitization.
    Sakuma H; Kohyama K; Jee Y; Matsumoto Y
    J Immunol; 2004 Oct; 173(7):4516-22. PubMed ID: 15383583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.